umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
LRIG inhibitors of growth factor signalling - double-edged swords in human cancer?
Umeå University, Faculty of Medicine, Radiation Sciences, Oncology.
Umeå University, Faculty of Medicine, Radiation Sciences, Oncology.
2007 (English)In: Eur J Cancer, ISSN 0959-8049, Vol. 43, no 4, 676-682 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2007. Vol. 43, no 4, 676-682 p.
Keyword [en]
LRIG, EGFR, ErbB, Tumour suppressor, Receptor tyrosine kinase
Identifiers
URN: urn:nbn:se:umu:diva-12261DOI: doi:10.1016/j.ejca.2006.10.021PubMedID: 17239582OAI: oai:DiVA.org:umu-12261DiVA: diva2:151932
Available from: 2007-03-28 Created: 2007-03-28 Last updated: 2011-01-11Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Hedman, HåkanHenriksson, Roger
By organisation
Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 65 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf